Vaccine to prevent STDs also effective in preventing cervical cancer, new breakthrough research shows

A series of vaccines given to protect against a group of sexually transmitted diseases are highly effective in preventing cancer.

The human papillomavirus (HPV) vaccine is administered in two doses; The first is applied at the age of 11 and the second is applied after 6 to 12 months.

Girls vaccinated before age 16 are 80 percent less likely to develop cervical cancer later in life, two new analyzes from the Cochrane Institute, considered the gold standard in clinical research, have found.

Researchers also found across more than 132 million patients that there was a ‘significant reduction’ in pre-cancerous cervical lesions in vaccinated individuals, reducing their risk of developing the disease later in life.

The vaccines are not linked to serious adverse side effects and may likely only cause minor, short-term problems, such as arm soreness, the researchers said.

Cervical cancer is the fourth most common cancer among women worldwide. About 90 percent of cases are caused by persistent infection with HPV, a virus that is often spread through sexual contact and can cause cancer-causing mutations in cervical cells.

Cervical cancer rates fell by more than half in the U.S. between the mid-1970s and the 2000s, largely due to widespread cancer screening, but after the HPV vaccine became available to 20- to 24-year-olds in 2006, rates fell another 11 percent between 2012 and 2021..

According to CDC data, 62.9 percent of children ages 13 to 17 in the United States currently receive HPV vaccines; This rate was 61.4 percent the previous year and this rate was a record nationwide.

The chart above shows the proportion of children ages 13 to 17 who are vaccinated against HPV.

But that’s below the World Health Organization’s goal of vaccinating 90 percent of children, the level experts say is needed to stop the spread of HPV.

According to estimates, approximately 13,360 women are diagnosed with cervical cancer each year in the United States and 4,320 women die from the disease.

Approximately 42 million Americans are estimated to be infected with HPV, according to the CDC, and approximately 13 million are said to become infected each year.

The virus is spread through skin-to-skin contact, such as oral, anal and genital sex, and may not cause any symptoms, although it can cause genital or anal warts. In most cases it clears up on its own within two years, but in some cases it can remain in the body for decades.

It is estimated that approximately 36,000 cancers are caused by viruses each year. Infection is also linked to cancers of the throat, mouth, vulva, penis, vagina, penis and anus.

One of the senior authors on the analysis, UK gynecologist Dr. Jo Morrison said: ‘These reviews make clear that HPV vaccination in early adolescence can prevent cancer and save lives.

‘Vaccinating boys as well as girls increases protection for everyone. ‘Over time we will see the impact of the vaccine on other cancers, including cancers affecting men.’

President of Cochrane Response and one of the leading authors of the analyses, Dr. Nicholas Henschke added: ‘We now have clear and consistent evidence from around the world that the HPV vaccine prevents cervical cancer.

LeAnn Rimes, pictured above, who attended the CMA Awards in November, announced that she had minor surgery to remove abnormal cells found during a routine pap smear test last year. There is no evidence of cervical cancer

‘A key finding was that the widely reported side effects of the vaccine, frequently discussed on social media, contained no evidence of an actual link to the vaccine.’

The review noted that social media users linked the vaccines to stroke, infertility, chronic fatigue syndrome and complex regional pain syndrome, or a persistent burning sensation in the arms, legs, hands or feet, but their analysis found no link between the vaccine and these conditions.

inside first analysisResearchers analyzed data from 60 studies involving more than 157,000 participants.

They found that all HPV vaccines, including Cervarix, Gardasil, and Gardasil-9, were effective in preventing HPV infections. They also showed no significant side effects.

The CDC says HPV vaccines are nearly 100 percent effective at preventing virus infections.

Among women ages 15 to 25, those who received the vaccine had a lower risk of being diagnosed with precancerous changes in the cervix or needing treatment for HPV-related problems, the researchers said. He did not give a percentage.

inside second analysisResearchers analyzed data from 225 studies covering 132 million people worldwide.

They found that HPV vaccination before age 16 reduced the risk of cervical cancer by 80 percent. They also said it significantly reduces the risk of pre-cancerous changes in the cervix.

Doctors want more young people to get vaccinated against the virus to reduce the risk of various types of cancer

The analysis also noted that there were significant reductions in anogenital warts, warts on the genitals and anus among those vaccinated before the age of 16, compared to older age groups.

The study also found no evidence that the HPV vaccine increases the risk of serious side effects.

Limitations of the studies were that most of the studies from which the new studies were taken were conducted in high-income countries. More studies are needed in middle- and low-income countries to confirm the results, the researchers said.

American surgeon Dr., who is also one of the senior authors of the studies. Hanna Vergman said: ‘Clinical trials cannot yet show us the full picture of cervical cancer as HPV-related cancers can take many years to develop.

‘However, the evidence from these trials confirms that HPV vaccines are highly effective in preventing cancer-causing infections, with no signs of serious safety concerns.’